Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00008528
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2001-01-12
Brief Title:
T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment andor Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs
Sponsor:
Organization:
NIH AIDS Clinical Trials Information Service
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
525
Enrollment Type:
None
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: